Community-acquired pneumonia is a serious public health issue with high morbidity and death, and hospitalizations for pneumonia appear to be on the rise. It is debatable whether mortality is currently declining, and this is influenced by a number of factors, including an aging population and an increase in comorbidities, microbiological and antibiotic changes, management improvements in intensive care units, pneumococcal and influenza vaccines, and immunomodulatory treatments. Despite the variability of data, some significant publications have been published in recent years, indicating a progressive drop in mortality despite an increase in patient age and comorbidities. However, further efforts are required to achieve a more significant improvement in these individuals’ prognoses. Improved adherence to recommendations, more stringent sepsis care, and improved vaccination outcomes, for example, are all necessary. Furthermore, new and improved diagnostic tests and antibiotic regimens, as well as better identification of individuals who may benefit from immunomodulatory treatment, are likely to be required. Reference:journals.lww.com/clinpulm/Abstract/2017/11000/Has_Mortality_of_Community_Acquired_Pneumonia.5.aspx
"really" - Google News
December 31, 2021 at 05:23PM
https://ift.tt/3sV1twu
Is The Mortality Rate of Community-Acquired Pneumonia Really Lower? - Physician's Weekly
"really" - Google News
https://ift.tt/3b3YJ3H
https://ift.tt/35qAk7d
Bagikan Berita Ini
0 Response to "Is The Mortality Rate of Community-Acquired Pneumonia Really Lower? - Physician's Weekly"
Post a Comment